CStone Pharmaceuticals Stock Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Delayed
Deutsche Boerse AG
09:25:01 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 0.6242 EUR | +0.42% |
|
+12.19% | +9.51% |
| 09-24 | CStone Pharma CEO Buys HK$2.7 Million of Shares | MT |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| Market Cap | 7.71B 1.15B 1.02B 954M 869M 1.64B 111B 1.65B 11.54B 4.47B 56.52B 4.32B 4.22B 181B | P/E 2026 * |
-16.7x | P/E 2027 * | 4.52x |
|---|---|---|---|---|---|
| Enterprise Value | 6.73B 1B 892M 833M 759M 1.43B 96.54B 1.44B 10.08B 3.91B 49.35B 3.77B 3.69B 158B | EV / Sales 2026 * |
15.9x | EV / Sales 2027 * | 2.14x |
| Free-Float |
79.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2616 | Delayed | |
OTC Markets
| CSPHF | Delayed | |
|
Deutsche Boerse AG
| PH4 | Delayed | |
|
Tradegate
| PH4 | Real-time | |
|
Börse Stuttgart
| PH4 | Delayed | |
|
Boerse Muenchen
| PH4 | Real-time |
Last Transcript: CStone Pharmaceuticals
| 1 day | +0.42% | ||
| 1 week | +12.19% | ||
| Current month | -2.47% | ||
| 1 month | -3.46% | ||
| 3 months | +6.26% | ||
| 6 months | -36.44% | ||
| Current year | +9.51% |
| 1 week | 0.61 |  | 0.66 |
| 1 month | 0.55 | | 0.67 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.45 | | 1.12 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.35 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 2022-08-24 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 2023-01-17 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 2016-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 2022-08-24 |
Edward Hu
BRD | Director/Board Member | 63 | 2021-07-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | +12.19% | - | - | 1.15B | |
| +0.25% | -2.97% | +36.03% | +112.30% | 1,019B | |
| -0.89% | -6.71% | +34.83% | +61.44% | 617B | |
| -0.56% | -1.69% | +13.73% | +77.54% | 464B | |
| -3.17% | -6.29% | +56.90% | +34.49% | 356B | |
| +0.27% | -2.42% | +20.25% | +40.58% | 333B | |
| -0.12% | -4.25% | +9.87% | +33.26% | 267B | |
| -0.94% | -5.88% | -7.61% | +7.84% | 244B | |
| -0.84% | -4.32% | +36.03% | +50.93% | 218B | |
| -1.09% | -5.87% | +26.14% | +91.79% | 179B | |
| Average | -0.66% | -3.54% | +25.13% | +56.69% | 410.8B | |
| Weighted average by Cap. | -0.61% | -3.54% | +28.37% | +68.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 423M 63.11M 56.07M 52.34M 47.7M 89.97M 6.07B 90.81M 633M 245M 3.1B 237M 232M 9.95B | 1.72B 257M 228M 213M 194M 366M 24.69B 370M 2.58B 999M 12.62B 964M 943M 40.51B |
| Net income | -384M -57.2M -50.83M -47.44M -43.24M -81.55M -5.5B -82.31M -574M -222M -2.81B -215M -210M -9.02B | 680M 101M 90.17M 84.16M 76.71M 145M 9.76B 146M 1.02B 395M 4.99B 381M 373M 16.01B |
| Net Debt | -978M -146M -130M -121M -110M -208M -14.02B -210M -1.46B -567M -7.17B -547M -536M -23B | -4.02B -600M -533M -498M -453M -855M -57.68B -863M -6.02B -2.33B -29.49B -2.25B -2.2B -94.63B |
| Date | Price | Change |
|---|---|---|
| 26-10-05 | €0.6242 | +0.42% |
| 26-10-02 | €0.6216 | -2.63% |
| 26-10-01 | €0.6384 | -0.25% |
| 26-09-30 | €0.6400 | +4.85% |
| 26-09-29 | €0.6104 | +9.71% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
